Novocodex Biopharmaceuticals

Developer of antibodies for treating cancer

placeShaoxing, Zhejiang, China calendar_todayFounded 2017 groups104 employees language novocodex.cn

3 investors on record; lead investors include Lilly, Matrix.

Investor type	Count	Share
Venture capital	1	33%
Other / undisclosed	2	67%

Coming soon